Nanobiotix SA (NANO) EUR0.03
Sell:€10.50Buy:€10.92
€1.76
(19.43%)
- This stock can be held in a
Create an alert
Stocks and Shares ISA€1.76
(19.43%)€1.76
(19.43%)Company Information
About this company
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Key people
Key facts
- EPICNANO
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINFR0011341205
- Market cap€434.36m
- Employees108
- Shares in issue47.43m
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.